70.10.Z - Head office activities
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
64.19.Z - Other monetary intermediation
64.91.Z - Financial leasing
64.92.Z - Other forms of credit granting
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
68.20.Z - Rental and management of own or leased real estate
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 176,1 | 154,8 | -10,4 | -106,7 |
EBITDA | 74,9 | 75,9 | -10,4 | -113,7 |
Short time liabilities | 9,3 | 14,1 | 16,8 | 19,5 |
Equity capital | 566,8 | 707,2 | 689,4 | -2,5 |
Operating profit (EBIT) | 74,9 | 75,9 | -10,4 | -113,7 |
Assets | 576,1 | 721,2 | 706,2 | -2,1 |
Net profit (loss) | 159,6 | 140,4 | -10,4 | -107,4 |
Cash | 305,4 | 457,4 | 440 | -3,8 |
Net income from sale | 176,7 | 184,4 | 175,3 | -4,9 |
Liabilities and provisions for liabilities | 9,3 | 14,1 | 16,8 | 19,5 |
Working assets | 332,1 | 477,3 | 462,3 | -3,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 28,2 | 19,8 | -1,5 | -21,3 |
Equity capital to total assets | 98,4 | 98,1 | 97,6 | -0,5 |
Gross profit margin | 99,7 | 83,9 | -5,9 | -89,8 |
EBITDA Margin | 42,4 | 41,2 | -5,9 | -47,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 28 | 35 | 7 |
Current financial liquidity indicator | 35.87294387817383 | 33.94565963745117 | 27.506319046020508 | -6,4 |
Net dept to EBITDA | -4.074589252471924 | -6.0244927406311035 | 42.25802230834961 | 48,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane